A detailed history of N Verses Capital, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 2,200 shares of TMDX stock, worth $134,244. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,200
Previous 1,600 37.5%
Holding current value
$134,244
Previous $241 Million 43.32%
% of portfolio
0.16%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$135.68 - $176.11 $81,408 - $105,666
600 Added 37.5%
2,200 $345 Million
Q2 2024

Jul 31, 2024

BUY
$72.62 - $150.62 $116,192 - $240,992
1,600 New
1,600 $241 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.94B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.